SCHEMBL30401203

SCHEMBL30401203

N#Cc1cccc(-c2cc(-c3cn(Cc4cccc(N5CC[C@@H](C(=O)O)C5)n4)nn3)nc(N)n2)c1

nearest known ligand 0.44

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.44
▸ ADORA2A P29274 13/20 0.42
▸ ADORA2B P29275 10/20 0.42
▸ ADORA1 P30542 2/20 0.42
▸ PDE4D Q08499 2/20 0.42
▸ PDE4A P27815 1/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ PDE4C Q08493 1/20 0.42
▸ DGAT2 Q96PD7 1/20 0.37
▸ LRRK2 Q5S007 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30401568 1.00 NOTUM (0.44) NOTUMADORA2AADORA2BADORA1PDE4D
SCHEMBL20416789 1.00 NOTUM (0.44) NOTUMADORA2AADORA2BADORA1PDE4D
SCHEMBL30402083 1.00 NOTUM (0.44) NOTUMADORA2AADORA2BADORA1PDE4D
SCHEMBL20416790 1.00 NOTUM (0.44) NOTUMADORA2AADORA2BADORA1PDE4D
SCHEMBL20416785 1.00 NOTUM (0.44) NOTUMADORA2AADORA2BADORA1PDE4D
SCHEMBL30401861 0.96 DGAT2 (0.42) NOTUMADORA2AADORA2BADORA1PDE4D
SCHEMBL20417123 0.96 DGAT2 (0.42) NOTUMADORA2AADORA2BADORA1PDE4D
SCHEMBL20416775 0.95 PDE4D (0.46) NOTUMADORA2AADORA2BADORA1PDE4D
SCHEMBL30401961 0.95 PDE4D (0.46) NOTUMADORA2AADORA2BADORA1PDE4D
SCHEMBL20421978 0.94 ADORA2A (0.46) ADORA2AADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116768859-A Azolopyrimidines for the treatment of cancer related disorders 艾库斯生物科学有限公司 2023-09-19 — — CN disclosed
CN-110214012-B Azolopyrimidines for the treatment of cancer related disorders 艾库斯生物科学有限公司 2023-05-09 — — CN disclosed
Send feedback